impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Letters to the Editor

 

Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab

1, 2, 3

 

  1. Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Deutsches Zentrum für Immuntherapie (DZI) FAU Erlangen-Nürnberg and Universitätsklinikum Erlangen, Germany. larissa.valormendez@uk-erlangen.de
  2. Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Deutsches Zentrum für Immuntherapie (DZI) FAU Erlangen-Nürnberg and Universitätsklinikum Erlangen, Germany.
  3. Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Deutsches Zentrum für Immuntherapie (DZI) FAU Erlangen-Nürnberg and Universitätsklinikum Erlangen, Germany.

CER14634
2022 Vol.40, N°4
PI 0854, PF 0855
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 34796852 [PubMed]

Received: 15/03/2021
Accepted : 26/07/2021
In Press: 17/11/2021
Published: 04/05/2022

DOI: https://doi.org/10.55563/clinexprheumatol/m9dexe

Rheumatology Article